| Literature DB >> 29414921 |
Jingjing Du1, Yan Xu2, Peiwen Zhang3, Xue Zhao4, Mailin Gan5, Qiang Li6, Jideng Ma7, Guoqing Tang8, Yanzhi Jiang9, Jinyong Wang10, Xuewei Li11, Shunhua Zhang12, Li Zhu13.
Abstract
Intramuscular fat (IMF) content and composition are considered crucial indicators of porcine meat quality. However, the molecular mechanism of porcine IMF development is still mostly unclear. Recently, new evidence suggested that microRNA (miRNAs) play important roles in porcine intramuscular adipogenesis. Previously, microRNA-125a-5p (miR-125a-5p) was identified as an important regulator of adipogenesis. In the present study, we found that the expression of miR-125a-5p is dynamically regulated during porcine intramuscular preadipocytes differentiation and that its expression levels in different porcine muscle tissues were negatively involved with IMF content. To investigate the potential function role of miR-125a-5p in IMF development, porcine intramuscular preadipocytes were collected and transfected with miR-125a-5p mimics, inhibitors, or a negative control (NC), respectively. The results showed that overexpression of miR-125a-5p promoted proliferation and inhibited differentiation of porcine intramuscular preadipocytes while inhibition of miR-125a-5p had the opposite effects. Furthermore, a luciferase reporter assay demonstrated that porcine kruppel like factor 3 (KLF13) is a target gene of miR-125a-5p during porcine intramuscular preadipocytes differentiation. Interestingly, porcine ELOVL fatty acid elongase 6 (ELOVL6), a regulator of fatty acid composition, was also identified as a target gene of miR-125a-5p during porcine intramuscular adipogenesis. Further studies show that miR-125a-5p overexpression reduced total saturated fatty acids (SFA) content and monounsaturated fatty acids (MUFA)/SFA ratios while having no significant impact on polyunsaturated fatty acids (PUFA)/SFA and n-6/n-3 ratios. Taken together, our results identified that miR-125a-5p may be a novel regulator of porcine intramuscular adipogenesis and the fatty acid composition of porcine IMF.Entities:
Keywords: differentiation; fatty acid composition; intramuscular fat; kruppel like factor 3; micoRNA-125a-5p
Mesh:
Substances:
Year: 2018 PMID: 29414921 PMCID: PMC5855723 DOI: 10.3390/ijms19020501
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1miR-125a-5p was negatively associated with porcine intramuscular fat (IMF) content. (A) The relative expression levels of miR-125a-5p in psoas major muscle (PMM) and longissimus dorsi muscle (LDM) (n = 3 per sample); (B) content of porcine IMF in PMM and LDM (n = 3 per sample); (C) IMF content in tongue (TON), obliquus externus abdominis (OEA), gastrocnemius muscle (GAM), masseter (MAS), and peroneal longus (PEL) (n = 3 per sample); (D–F) expression levels of diacylglycerol O-acyltransferase 2 (DGAT2), ELOVL fatty acid elongase 6 (ELOVL6) and miR-125a-5p in TON, OEA, GAM, MAS, and PEL (n = 3 per sample); (G) the relative expression levels of miR-125a-5p during porcine intramuscular preadipocytes differentiation (n = 3 per sample per time point). All results are presented as mean ± SEM. * p < 0.05; ** p < 0.01.
Figure 2miR-125a-5p promoted proliferation of porcine intramuscular preadipocytes. (A) Relative expression levels of miR-125a-5p in porcine intramuscular preadipocytes transfected with miR-125a-5p mimics inhibitors or negative control (NC) (n = 3 per treatment); (B,C) 5-ethynyl-2′-deoxyuridine (EdU) proliferation and (D) Cell Counting kit 8 (CCK-8) assays were performed to determine cell proliferation (n = 6 per treatment per time point); (E) the relative expression levels of cyclin-dependent kinases 2 (CDK2), Cell cycle protein B (Cyclin B), cyclin-dependent kinases 3 (CDK3), cyclin-dependent kinases 4 (CDK4), and cyclin-dependent kinase inhibitor 1A (p21) when porcine intramuscular preadipocytes were transfected with mimics, inhibitors, or NC for 2 days (n = 3 per treatment). Scale bar, 100 μm. All results are presented as mean ± SEM. * p < 0.05; ** p < 0.01.
Figure 3miR-125a-5p inhibited differentiation of porcine intramuscular preadipocytes by directly targeting Kruppel-like factor 13 (KLF13). After porcine intramuscular preadipocytes were induced differentiate and transfected with miR-125a-5p mimics, inhibitors or negative control (NC) for 8 days, (A) the relative expression levels of miR-125a-5p were measured by qRT-PCR (n = 3 per treatment); (B) Cells were stained with oil red O (n = 3 per treatment); (C) triglycerides content was measured by spectrophotometric analysis (n = 4 per treatment); (D) immunofluorescence of adiponectin was performed (n = 3 per treatment); (E) The relative expression levels of genes related to adipocytes differentiation (n = 3 per treatment). Additionally, porcine intramuscular preadipocytes that were induced differentiated for 4 days and were transfected respectively with miR-125a-5p mimics, inhibitors, or NC. (F) Mitochondrial content were evaluated by measuring the ratio of mtDNA:nDNA (n = 3 per treatment); The relative expression levels of genes related to (G) mitochondrial biogenesis and (H) mitochondrial energy metabolism (n = 3 per treatment); (I) cells were stained with oil red O (n = 3 per treatment); (J) triglycerides content was measured by spectrophotometric analysis (n = 3 per treatment); (K) the relative expression levels of CCAAT/enhancer binding protein α (C/EBPα), and peroxisome proliferator activated receptor γ (PPARγ) (n = 3 per treatment); (L) The relative expression levels of miR-125a-5p and KLF13 during differentiation of porcine intramuscular preadipocytes (n = 3 per treatment per time point); (M) The expression levels of KLF13 after cells were transfected with mimics, inhibitors, or NC (n = 3 per treatment); (N) sequence alignment of Ssc-miR-125a-5p with 3′-UTR of porcine KLF13 mRNA; (O) Luciferase assays revealed the repressive effect of miR-125a-5p on the activity of KLF13 (n = 7 per treatment); (P) the expression levels of estrogen related receptor α (ERRα) after cells were transfected with mimics, inhibitors or NC (n = 3 per treatment). Scale bar, 100 μm. All results are presented as mean ± SEM. * p < 0.05; ** p < 0.01.
Figure 4miR-125a-5p affected fatty acid composition in porcine intramuscular adipocytes. (A) Sequence alignment of Ssc-miR-125a-5p with 3′-UTR of porcine ELOVL6 mRNA; (B) Luciferase assays revealed the repressive effect of miR-125a-5p on the activity of ELOVL6 (n = 7 per treatment). After porcine intramuscular adipocytes were transfected with mimics or NC; (C) the expression levels of ELOVL6 (n = 3 per treatment); (D) Saturated fatty acids (SFA) content in mimics group and control group (n = 3 per treatment); (E) Fatty acid composition difference (n = 3 per treatment); (F) monounsaturated fatty acids (MUFA)/SFA ration (n = 3 per treatment); (G) polyunsaturated fatty acids (PUFA)/SFA ration (n = 3 per treatment); (H) n-6/n-3 ration (n = 3 per treatment). All results are presented as mean ± SEM. n = 3. * p < 0.05; ** p < 0.01.
miR-125a-5p regulate fatty acid composition in porcine intramuscular adipocytes.
| Fatty Acid | NC | Mimics | Up/Down |
|---|---|---|---|
| C6:0 | 0.3489 | 0.3492 | down NS |
| C8:0 | 0.5118 | 0.5119 | down NS |
| C10:0 | 0.4812 | 0.4818 | down NS |
| C12:0 | 0.7860 | 0.7838 | down NS |
| C13:0 | 0.0000 | 0.0000 | - |
| C14:0 | 1.0003 | 0.8013 | down * |
| C15:0 | 0.4443 | 0.3914 | down * |
| C15:1 | 0.0000 | 0.0000 | - |
| C16:0 | 3.0437 | 2.3119 | down * |
| C16:1 | 2.2056 | 2.0297 | down * |
| C17:0 | 0.4456 | 0.4022 | down NS |
| C17:1 | 0.5076 | 0.7660 | up * |
| C18:0 | 4.1666 | 3.5791 | down * |
| C18:1n9t | 0.0000 | 0.0000 | - |
| C18:1n9c | 3.9273 | 3.6161 | down * |
| C18:2n6t | 0.0000 | 0.0000 | - |
| C18:2n6c | 1.2904 | 1.0772 | down NS |
| C18:3n3 | 0.0000 | 0.0000 | - |
| C18:3n6 | 1.1420 | 1.0054 | down NS |
| C20:0 | 0.8700 | 0.8703 | up NS |
| C20:2 | 1.3139 | 0.9447 | down * |
| C20:1 | 0.3175 | 0.6081 | up * |
| C20:3n3 | 0.7617 | 0.6041 | down* |
| C20:3n6 | 1.1683 | 1.1799 | up NS |
| C20:4n6 | 4.5844 | 3.9889 | down * |
| C20:5n3 | 11.5488 | 8.9343 | down ** |
| C21:0 | 0.0000 | 0.0000 | - |
| C22:0 | 0.0000 | 0.0000 | - |
| C22:1n9 | 0.0000 | 0.0000 | - |
| C22:2n6 | 0.0000 | 0.0000 | - |
| C22:6 | 3.3151 | 3.5985 | up NS |
| C24:0 | 0.0000 | 0.0000 | - |
| C24:1 | 0.0000 | 0.0000 | - |
| SFA | 12.0983 | 10.4831 | down * |
| PUFA | 26.3246 | 21.3331 | down * |
| MUFA | 6.9580 | 6.8200 | down NS |
| n-6 | 8.3851 | 7.1514 | down * |
| n-3 | 12.3105 | 9.8584 | down * |
Saturated fatty acid (SFA) = C8:0 + C10:0 + C12:0 + C14:0 + C15:0 + C16:0 + C17:0 + C18:0 + C20:0 + C22:0; Monounsaturated fatty acid (MUFA) = C14:1 + C16:1 + C18:1 + C20:1 + C24:1; Polyunsaturated fatty acid (PUFA) = C18:2 + C18:3 + C20:2 + C20:3 + C20:4 + C20:5 + C22:2 + C22:6; n-3 = C18:3n3 + C20:3n3 + C20:5n3; n-6 = C18:2n6t + C18:2n6c + C18:3n6 + C20:3n6 + C20:4n6 + C22:2n6. * p < 0.05; ** p < 0.01; NS, no significant difference.